Navigation Links
Carl Zeiss Offers Online Promotions
Date:3/17/2010

Carl Zeiss Offers Online Promotions – Discounts on Stereomicroscopy and Converting to 3D Imaging

Thornwood, N.Y. (PRWEB) March 17, 2010 -- Carl Zeiss, a leading provider of microscopy solutions for a variety of research, clinical and industrial applications, recently announced two exciting online promotions. For a limited time, and only available online, these special web promotions include a price reduction on Zeiss’s top-rated stereomicroscopy instrument and a 5 percent discount for conversion of certain existing models of Zeiss research microscopes into a 3D imaging workstation.

Purchase the SteREO Discovery V8 to explore the new standard in stereomicroscopy and discover the advantage of high performance optics for a special price of $4,995 (originally valued at more than $7,000). The newly designed optic system offers enhanced resolution, increased contrast, and a perceptibly improved stereoscopic impression.

The SteREO Discovery V8, with Manual Stand Base Profile S, offers brilliant 3D images, enabling an efficient observation and handling of samples. Also included is a long life LED ring light for shadow-free illumination and the 1.0X Zeiss V8 Achromat high-contrast objective for the most pronounced stereoscopic impression from 10x to 80x magnification. Go to http://www.zeiss.com/promo to order.

Go Confocal and receive a 5 percent discount for converting existing Zeiss research microscopes into a 3D imaging workstation. If your current microscope is not listed, you can also upgrade your stand at a special rate of $9,900. Promotion models include VivaTome Structured Illumination System, LSM 700 Laser Scanning Confocal Microscope, or Cell Observer® SD systems. Visit (www.zeiss.com/goconfocal).

About Carl Zeiss
Carl Zeiss MicroImaging, Inc., a subsidiary of Carl Zeiss, Inc., offers microscopy solutions and systems for research, laboratories, routine and industrial applications. In addition, Carl Zeiss MicroImaging markets microscopy and digital pathology systems for the clinical market, as well as spectral sensors for industrial and pharmaceutical applications. Since1846, Carl Zeiss has remained committed to enabling science and technology to go beyond what man can see. Today, Carl Zeiss is a global leader in the optical and opto-electronic industries.

With 11,249 current employees in the Group and offices in over 30 countries, Carl Zeiss is represented in more than 100 countries with production centers in Europe, North America, Central America and Asia. For more information on the breadth of solutions offered by Carl Zeiss MicroImaging, please visit www.zeiss.com/micro.

Attention publishers: Please forward all Sales Inquiries to: Karin A. Salerno, Marketing Communications Manager
Phone: (914) 681-7627

# # #

Read the full story at http://www.prweb.com/releases/2010/CarlZeiss/prweb3738834.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications
2. UC San Diegos Biotech Demystified Program Offers Science Basics for Industry Leaders
3. Danaher Offers to Acquire Genetix Group plc for GBP 50 million pounds Sterling (USD $82 million)
4. New Multicenter Study Finds That Cardiac Function Measured During Stress Testing With Cheetah Medicals BIOREACTANCE(R) Noninvasive Technology Offers New Insights Into Heart Failure
5. Will Jatropha Become a 'DotCom Bubble' in Biofuel Industry? Leading to 2nd JatrophaWorld Africa, Jatropha Webinar on 30 Sept 09 Explores Challenges & Offers Strategies for Long-Term Success for This Non-Food Crop for Fuel
6. New Sigma Advanced Genetic Engineering Labs Offers Research Community Unique Rodent Models Developed Using Exclusive Gene-Editing Technology
7. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
8. DNA Diagnostics Center Offers Father's Day DNA Testing
9. Plenish™ High Oleic Soybean Oil Offers Trans Fat Solution with Superior Performance
10. Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists
11. MMR Offers Free Surgical Masks to Call Attention to Importance of Personal Health Records in Preparing for Possible Swine Flu Pandemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... , March 23, 2017 According to ... products and derivatives market is fragmented due to the presence of a ... as Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each ... three companies, collectively, held more than 76% of this market in ... As of ...
(Date:3/23/2017)... NEW YORK , March 23, 2017 ... closer look at four equities in the Biotech industry: ... EYEG), Synthetic Biologics Inc. (NYSE MKT: SYN), and Regulus ... March 21 st , 2017, Credit Suisse upgraded its rating ... stocks by downloading their free report at: ...
Breaking Biology Technology:
(Date:3/16/2017)... CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in Germany ... ... one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... ...
(Date:3/7/2017)... , March 7, 2017   HireVue , ... top global companies identify the best talent, faster, today ... Chief Sales Officer (CSO) and Diana Kucer ... round out a seasoned executive team poised to drive continued ... building on a year of record bookings in 2017. ...
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
Breaking Biology News(10 mins):